Quick Answer
Seres Therapeutics, Inc. reported Common Stock Shares Outstanding of 9.56 million shares for the year ending 2025.
- Seres Therapeutics, Inc. showed an increase of +10.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Seres Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: 30.42 million shares | Q3 2015: 39.06 million shares | Q1 2016: 39.22 million shares | Q2 2016: 39.86 million shares | Q3 2016: 40.36 million shares | Q1 2017: 40.39 million shares | Q2 2017: 40.41 million shares | Q3 2017: 40.51 million shares | Q1 2018: 40.65 million shares | Q2 2018: 40.75 million shares | Q3 2018: 40.84 million shares | Q1 2019: 41.09 million shares | Q2 2019: 69.91 million shares | Q3 2019: 69.99 million shares | Q1 2020: 71.67 million shares | Q2 2020: 75.13 million shares | Q3 2020: 91.21 million shares | Q1 2021: 91.59 million shares | Q2 2021: 91.71 million shares | Q3 2021: 91.84 million shares | Q1 2022: 92.21 million shares | Q2 2022: 92.31 million shares | Q3 2022: 124.41 million shares | Q1 2023: 126.59 million shares | Q2 2023: 128.04 million shares | Q3 2023: 128.63 million shares | Q1 2024: 151.44 million shares | Q2 2024: 151.63 million shares | Q3 2024: 170.20 million shares | Q1 2025: 8.73 million shares | Q2 2025: 8.75 million shares | Q3 2025: 8.76 million shares.
- Over the full 12 years of available data (2014 to 2025), Seres Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 38.7%.
- Historical annual values: Fiscal year 2025: 9.56 million shares | Fiscal year 2024: 8.65 million shares | Fiscal year 2023: 135.04 million shares | Fiscal year 2022: 125.22 million shares | Fiscal year 2021: 91.89 million shares | Fiscal year 2020: 91.46 million shares | Fiscal year 2019: 70.14 million shares | Fiscal year 2018: 40.94 million shares | Fiscal year 2017: 40.57 million shares | Fiscal year 2016: 40.36 million shares | Fiscal year 2015: 39.08 million shares | Fiscal year 2014: 6.89 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: